ACS
GSK icon

Archford Capital Strategies’s GSK GSK Stock Holding History

Archford Capital Strategies’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-30,759
Closed -$1.7M – 365
2026
Q1 		$1.7M Buy
+30,759
New +$1.67M 0.19% 114
2019
Q3 		– Sell
-280
Closed -$14K – 341
2019
Q2 		$14K Hold
280
– – 0.01% 380
2019
Q1 		$15K Hold
280
– – 0.01% 362
2018
Q4 		$13K Hold
280
– – 0.01% 356
2018
Q3 		$14K Hold
280
– – 0.01% 389
2018
Q2 		$14K Buy
280
+8
+3% +$403 ﹤0.01% 396
2018
Q1 		$12K Buy
+272
New +$12.7K 0.01% 320
2017
Q2 		– Sell
-698
Closed -$37K – 359
2017
Q1 		$37K Buy
698
+192
+38% +$9.74K 0.01% 308
2016
Q4 		$24K Sell
506
-180
-26% -$8.89K 0.01% 307
2016
Q3 		$36K Hold
686
– – 0.01% 286
2016
Q2 		$37K Buy
+686
New +$36.1K 0.02% 278
2016
Q1 		– Sell
-620
Closed -$32K – 342
2015
Q4 		$32K Buy
620
+40
+7% +$2.04K 0.01% 314
2015
Q3 		$28K Sell
580
-1,566
-73% -$81.5K 0.02% 238
2015
Q2 		$112K Sell
2,146
-45
-2% -$2.53K 0.08% 148
2015
Q1 		$126K Hold
2,191
– – 0.09% 140
2014
Q4 		$117K Sell
2,191
-4,794
-69% -$268K 0.09% 146
2014
Q3 		$401K Buy
6,985
+367
+6% +$22.5K 0.32% 88
2014
Q2 		$442K Sell
6,618
-268
-4% -$18.1K 0.34% 84
2014
Q1 		$460K Buy
+6,886
New +$466K 0.38% 81

Other funds holding GSK

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
SIS
Sound Income Strategies Ft Lauderdale, Florida $2.23B AUM 11.22% 1-Year Est. Return
KFP
Keystone Financial Planning Cleveland, Ohio $388M AUM 16.66% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
GC
Grimes & Company Westborough, Massachusetts $4.62B AUM 29.71% 1-Year Est. Return
BB
Bell Bank Fargo, North Dakota $2.62B AUM 23.93% 1-Year Est. Return
KIC
Keating Investment Counselors Delray Beach, Florida $364M AUM 22.11% 1-Year Est. Return

Archford Capital Strategies's GSK Position: Q2 2026 in Review

Archford Capital Strategies sold out of GSK (GSK) in Q2 2026, closing a stake of 30,759 shares — an estimated $1.7M sold.

Archford Capital Strategies first reported a position in GSK in Q1 2014 and held it in 19 quarters. The position peaked at $1.7M in Q1 2026. 186 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Archford Capital Strategies reported no remaining GSK position as of Q2 2026 after selling out during the quarter.
  • Archford Capital Strategies sold 30,759 GSK shares in Q2 2026, an estimated $1.7M.
  • Archford Capital Strategies first reported a position in GSK in Q1 2014 and held it in 19 quarters.
  • Archford Capital Strategies's GSK position peaked at $1.7M in Q1 2026.
  • 186 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Archford Capital Strategies's 13F filing for Q2 2026, filed 17 Jul 2026.